• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.增生性玻璃体视网膜病变患者玻璃体中骨桥蛋白和其他血管生成及纤维化调节因子。
Mediators Inflamm. 2012;2012:493043. doi: 10.1155/2012/493043. Epub 2012 Sep 29.
2
Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.增殖性玻璃体视网膜病变发生前血管内皮生长因子与色素上皮生长因子的平衡
Ophthalmic Res. 2007;39(3):148-54. doi: 10.1159/000103234. Epub 2007 May 25.
3
Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.增生型糖尿病视网膜病变患者玻璃体液、血浆和死后视网膜组织中血管生成和血管抑制因子水平失衡。
J Diabetes Complications. 2012 Sep-Oct;26(5):435-41. doi: 10.1016/j.jdiacomp.2012.05.005. Epub 2012 Jun 12.
4
Upregulation of RAGE and its ligands in proliferative retinal disease.增殖性视网膜疾病中晚期糖基化终末产物受体(RAGE)及其配体的上调
Exp Eye Res. 2006 May;82(5):807-15. doi: 10.1016/j.exer.2005.09.022. Epub 2005 Dec 20.
5
Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.可溶性血管内皮生长因子受体-1在增生性糖尿病视网膜病变玻璃体中的作用。
Ophthalmology. 2008 Nov;115(11):1916-22. doi: 10.1016/j.ophtha.2008.06.025. Epub 2008 Aug 21.
6
Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.高迁移率族蛋白盒1/晚期糖基化终末产物受体/骨桥蛋白/早期生长反应1通路在增殖性玻璃体视网膜前膜中的表达
Mol Vis. 2011 Feb 17;17:508-18.
7
Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.增殖型糖尿病视网膜病变患者玻璃体内纤维胶凝蛋白-3 与血管内皮生长因子/色素上皮衍生因子比值的相关性。
Am J Ophthalmol. 2011 Dec;152(6):1039-43. doi: 10.1016/j.ajo.2011.05.022.
8
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.增殖性糖尿病视网膜病变和增殖性玻璃体视网膜病变中的趋化因子
Eur Cytokine Netw. 2006 Sep;17(3):155-65.
9
Soluble TNF receptors in vitreoretinal proliferative disease.玻璃体视网膜增殖性疾病中的可溶性肿瘤坏死因子受体
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1586-91.
10
Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体中的增殖和炎症因子
Indian J Ophthalmol. 2015 Jan;63(1):33-6. doi: 10.4103/0301-4738.151464.

引用本文的文献

1
Determination of osteopontin in monitoring retinal damage in metabolic syndrome.测定骨桥蛋白在代谢综合征视网膜损伤监测中的作用。
Int J Exp Pathol. 2024 Dec;105(6):206-218. doi: 10.1111/iep.12518. Epub 2024 Oct 13.
2
TLR2 and TLR4 Are Expressed in Epiretinal Membranes: Possible Links with Vitreous Levels of Complement Fragments and DAMP-Related Proteins.TLR2 和 TLR4 在视网膜前膜中表达:与玻璃体液中补体片段和 DAMPs 相关蛋白的可能联系。
Int J Mol Sci. 2024 Jul 15;25(14):7732. doi: 10.3390/ijms25147732.
3
RAGE plays key role in diabetic retinopathy: a review.RAGE 在糖尿病视网膜病变中发挥关键作用:综述。
Biomed Eng Online. 2023 Dec 19;22(1):128. doi: 10.1186/s12938-023-01194-9.
4
Receptors that bind to PEDF and their therapeutic roles in retinal diseases.与 PEDF 结合的受体及其在视网膜疾病中的治疗作用。
Front Endocrinol (Lausanne). 2023 Apr 17;14:1116136. doi: 10.3389/fendo.2023.1116136. eCollection 2023.
5
Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases.玻璃体蛋白质组学分析显示,补体和凝血成分、黏附因子以及神经退行性变标志物可作为区分玻璃体视网膜眼病的生物标志物。
Front Immunol. 2023 Feb 16;14:1107295. doi: 10.3389/fimmu.2023.1107295. eCollection 2023.
6
Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers.糖尿病视网膜病变:可溶性及影像学眼部生物标志物
J Clin Med. 2023 Jan 24;12(3):912. doi: 10.3390/jcm12030912.
7
Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases.玻璃体视网膜疾病的增殖和新生血管形成的分子机制的研究进展。
Cell Mol Life Sci. 2022 Dec 31;80(1):22. doi: 10.1007/s00018-022-04670-y.
8
Differences in Vitreous Protein Profiles in Patients With Proliferative Diabetic Retinopathy Before and After Ranibizumab Treatment.雷珠单抗治疗前后增殖性糖尿病视网膜病变患者玻璃体蛋白质谱的差异
Front Med (Lausanne). 2022 May 27;9:776855. doi: 10.3389/fmed.2022.776855. eCollection 2022.
9
Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus Darbepoetin.两项关于罗沙司他与达比加群酯眼科效应的3期研究。 (注:原文中“Darbepoetin”有误,正确的应该是“Darbepoetin alfa”,通用名是“阿法依泊汀” ,译文按照正确的进行了修正,若严格按照错误原文翻译则为:两项关于罗沙司他与达比泊汀眼科效应的3期研究 。)
Kidney Int Rep. 2022 Jan 19;7(4):763-775. doi: 10.1016/j.ekir.2022.01.1045. eCollection 2022 Apr.
10
Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.损伤相关分子模式(DAMPs)在视网膜疾病中的作用。
Int J Mol Sci. 2022 Feb 26;23(5):2591. doi: 10.3390/ijms23052591.

本文引用的文献

1
Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy.增生型糖尿病视网膜病变患者玻璃体内的血管生成调控因子。
Acta Diabetol. 2013 Aug;50(4):545-51. doi: 10.1007/s00592-011-0330-9. Epub 2011 Sep 25.
2
High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.高迁移率族蛋白盒1与增殖性糖尿病视网膜病变患者玻璃体内的炎症生物标志物
Mol Vis. 2011;17:1829-38. Epub 2011 Jul 6.
3
Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells.骨桥蛋白过表达通过 avβ3/PI3K/AKT/eNOS/NO 信号通路诱导内皮祖细胞在胶质瘤细胞中的血管生成。
Eur J Cell Biol. 2011 Aug;90(8):642-8. doi: 10.1016/j.ejcb.2011.03.005. Epub 2011 May 26.
4
Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis.骨桥蛋白调节纤维化小鼠模型吸入石棉后炎症、粘蛋白产生和基因表达特征。
Am J Pathol. 2011 May;178(5):1975-85. doi: 10.1016/j.ajpath.2011.01.048.
5
Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.高迁移率族蛋白盒1/晚期糖基化终末产物受体/骨桥蛋白/早期生长反应1通路在增殖性玻璃体视网膜前膜中的表达
Mol Vis. 2011 Feb 17;17:508-18.
6
Expression of myofibroblast activation molecules in proliferative vitreoretinopathy epiretinal membranes.成纤维细胞激活分子在增殖性玻璃体视网膜病变视网膜前膜中的表达。
Acta Ophthalmol. 2011 Mar;89(2):e115-21. doi: 10.1111/j.1755-3768.2010.01916.x.
7
Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via RAGE-dependent ERK1/2 activation.高迁移率族蛋白 B1 通过 RAGE 依赖性 ERK1/2 激活促进 3T3 小鼠成纤维细胞的伤口愈合。
Cell Biochem Biophys. 2010 May;57(1):9-17. doi: 10.1007/s12013-010-9077-0.
8
HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells.高迁移率族蛋白 B1 通过晚期糖基化终末产物受体激活核因子-κB 信号通路,增加人脐静脉内皮细胞肿瘤坏死因子-α的产生。
Immunobiology. 2010 Dec;215(12):956-62. doi: 10.1016/j.imbio.2009.11.001. Epub 2010 Feb 18.
9
Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.骨桥蛋白的抑制作用可抑制子宫内膜癌的体外和体内血管生成。
Gynecol Oncol. 2009 Dec;115(3):371-6. doi: 10.1016/j.ygyno.2009.08.029. Epub 2009 Sep 23.
10
Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜分支静脉阻塞继发黄斑水肿后房水血管内皮生长因子和色素上皮衍生因子的变化
Clin Exp Ophthalmol. 2009 Jul;37(5):490-5. doi: 10.1111/j.1442-9071.2009.02061.x.

增生性玻璃体视网膜病变患者玻璃体中骨桥蛋白和其他血管生成及纤维化调节因子。

Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.

机构信息

Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi

出版信息

Mediators Inflamm. 2012;2012:493043. doi: 10.1155/2012/493043. Epub 2012 Sep 29.

DOI:10.1155/2012/493043
PMID:23055574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3465918/
Abstract

The aim of this study was to determine the levels of the angiogenic and fibrogenic factors osteopontin (OPN), high-mobility group box-1 (HMGB1), and connective tissue growth factor (CTGF) and the antiangiogenic and antifibrogenic pigment epithelium-derived factor (PEDF) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR), and rhegmatogenous retinal detachment with no PVR (RD). Vitreous samples from 48 PDR, 17 PVR and 30 RD patients were studied by enzyme-linked immunosorbent assay. OPN, HMGB1, CTGF, and PEDF levels were significantly higher in PDR patients than in RD patients (P < 0.001; 0.002; <0.001; <0.001, resp.). CTGF and PEDF levels were significantly higher in PVR patients than in RD patients (P < 0.001; 0.004, resp.). Exploratory logistic regression analysis identified significant associations between PDR and high levels of HMGB1, CTGF and PEDF, between PDR with active neovascularization and high levels of CTGF and PEDF, and between PDR with traction retinal detachment and high levels of HMGB1. In patients with PDR, there were significant correlations between the levels of PEDF and the levels of OPN (r = 0.544, P = 0.001), HMGB1 (r = 0.719, P < 0.001), and CTGF (r = 0.715, P < 0.001). In patients with PVR, there were significant correlations between the levels of OPN and the levels of HMGB1 (r = 0.484, P = 0.049) and PEDF (r = 0.559, P = 0.02). Our findings suggest that OPN, HMGB1, and CTGF contribute to the pathogenesis of proliferative vitreoretinal disorders and that increased levels of PEDF may be a response to counterbalance the activity of angiogenic and fibrogenic factors in PDR and PVR.

摘要

本研究旨在确定骨桥蛋白(OPN)、高迁移率族蛋白 1(HMGB1)和结缔组织生长因子(CTGF)等血管生成和纤维生成因子以及抗血管生成和抗纤维生成的色素上皮衍生因子(PEDF)在增生性糖尿病视网膜病变(PDR)、增生性玻璃体视网膜病变(PVR)和无 PVR 的孔源性视网膜脱离(RD)患者玻璃体中的水平。通过酶联免疫吸附试验研究了 48 例 PDR、17 例 PVR 和 30 例 RD 患者的玻璃体样本。OPN、HMGB1、CTGF 和 PEDF 水平在 PDR 患者中显著高于 RD 患者(P<0.001;0.002;<0.001;<0.001,分别)。CTGF 和 PEDF 水平在 PVR 患者中显著高于 RD 患者(P<0.001;0.004,分别)。探索性逻辑回归分析确定了 PDR 与高水平 HMGB1、CTGF 和 PEDF 之间、PDR 与活跃新生血管形成与高水平 CTGF 和 PEDF 之间、PDR 与牵引性视网膜脱离与高水平 HMGB1 之间的显著关联。在 PDR 患者中,PEDF 水平与 OPN(r=0.544,P=0.001)、HMGB1(r=0.719,P<0.001)和 CTGF(r=0.715,P<0.001)水平之间存在显著相关性。在 PVR 患者中,OPN 水平与 HMGB1(r=0.484,P=0.049)和 PEDF(r=0.559,P=0.02)水平之间存在显著相关性。我们的研究结果表明,OPN、HMGB1 和 CTGF 有助于增生性玻璃体视网膜疾病的发病机制,PEDF 水平升高可能是对 PDR 和 PVR 中血管生成和纤维生成因子活性的一种平衡反应。